
Core Insights - Digital Ally, Inc. has signed a Master Distribution Agreement with Redwood Scientific Technologies, granting exclusive global rights to distribute Redwood's nicotine cessation products, including TBX-Free and TBX Vape-Free [1][2] - The TBX Vape-Free product is designed to help users overcome vape-related nicotine dependency and is expected to be the first of its kind in the market [2][4] - Digital Ally aims to launch the product following the successful completion of Redwood's final-stage clinical trial, with preparations for full-scale distribution already underway [6] Product Overview - Redwood's product suite includes TBX-Free, an oral thin-film strip aimed at helping cigarette smokers overcome nicotine addiction, utilizing natural active ingredients [3] - TBX Vape-Free is a first-to-market oral thin-film strip specifically developed for vape users, filling a critical gap in addiction treatment [4] Market Context - According to the CDC, approximately 11.6% of U.S. adults are current cigarette smokers, equating to about 28.8 million individuals, while 4.5% of adults aged 18 and over report current e-cigarette use [5] - Cigarette smoking is the leading cause of preventable disease and death in the U.S., responsible for over 480,000 deaths annually [5]